129 related articles for article (PubMed ID: 30885025)
21. Challenging a dogma; AJCC 8th staging system is not sufficient to predict outcomes of patients with malignant pleural mesothelioma.
Abdel-Rahman O
Lung Cancer; 2017 Nov; 113():128-133. PubMed ID: 29110839
[TBL] [Abstract][Full Text] [Related]
22. The AJCC 8th Edition Staging System for Soft Tissue Sarcoma of the Extremities or Trunk: A Cohort Study of the SEER Database.
Cates JMM
J Natl Compr Canc Netw; 2018 Feb; 16(2):144-152. PubMed ID: 29439175
[No Abstract] [Full Text] [Related]
23. Assessment of the prognostic value of the 8th AJCC staging system for patients with clinically staged prostate cancer; A time to sub-classify stage IV?
Abdel-Rahman O
PLoS One; 2017; 12(11):e0188450. PubMed ID: 29182656
[TBL] [Abstract][Full Text] [Related]
24. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
[TBL] [Abstract][Full Text] [Related]
25. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
[TBL] [Abstract][Full Text] [Related]
26. Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study.
Lu J; Zheng ZF; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Huang CM; Zheng CH; Li P
Ann Surg Oncol; 2018 Jul; 25(7):2002-2011. PubMed ID: 29725896
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the 8th edition American Joint Commission on Cancer (AJCC) staging system for patients with intrahepatic cholangiocarcinoma: A surveillance, epidemiology, and end results (SEER) analysis.
Kim Y; Moris DP; Zhang XF; Bagante F; Spolverato G; Schmidt C; Dilhoff M; Pawlik TM
J Surg Oncol; 2017 Nov; 116(6):643-650. PubMed ID: 28608424
[TBL] [Abstract][Full Text] [Related]
28. Critical evaluation of the American Joint Commission on Cancer (AJCC) 8th edition staging system for patients with Hepatocellular Carcinoma (HCC): A Surveillance, Epidemiology, End Results (SEER) analysis.
Kamarajah SK; Frankel TL; Sonnenday C; Cho CS; Nathan H
J Surg Oncol; 2018 Mar; 117(4):644-650. PubMed ID: 29127719
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance, Epidemiology and End Results (SEER) Analysis.
Shao N; Xie C; Shi Y; Ye R; Long J; Shi H; Shan Z; Thompson AM; Lin Y
Cancer Manag Res; 2019; 11():1433-1442. PubMed ID: 30863154
[TBL] [Abstract][Full Text] [Related]
30. Anatomical location-based nodal staging system is superior to the 7th edition of the American Joint Committee on Cancer staging system among patients with surgically resected, histologically low-grade gastric cancer: A single institutional experience.
Chen MW; Chan CP; Lin YJ; Yen HH
PLoS One; 2019; 14(2):e0211836. PubMed ID: 30721261
[TBL] [Abstract][Full Text] [Related]
31. Modified staging classification for intrahepatic cholangiocarcinoma based on the sixth and seventh editions of the AJCC/UICC TNM staging systems.
Meng ZW; Pan W; Hong HJ; Chen JZ; Chen YL
Medicine (Baltimore); 2017 Aug; 96(34):e7891. PubMed ID: 28834905
[TBL] [Abstract][Full Text] [Related]
32. A homogenized approach to classify advanced gastric cancer patients with limited and adequate number of pathologically examined lymph nodes.
Seeruttun SR; Xu L; Wang F; Yi X; Fang C; Liu Z; Wang W; Zhou Z
Cancer Commun (Lond); 2019 Jun; 39(1):32. PubMed ID: 31182160
[TBL] [Abstract][Full Text] [Related]
33. Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database.
In H; Solsky I; Palis B; Langdon-Embry M; Ajani J; Sano T
Ann Surg Oncol; 2017 Nov; 24(12):3683-3691. PubMed ID: 28895113
[TBL] [Abstract][Full Text] [Related]
34. Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer: results from a high-volume institution.
Lu J; Dai Y; Xie JW; Wang JB; Lin JX; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Li P; Huang CM
BMC Cancer; 2019 Mar; 19(1):216. PubMed ID: 30857518
[TBL] [Abstract][Full Text] [Related]
35. Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma.
Wang H; Lin Z; Li G; Zhang D; Yu D; Lin Q; Wang J; Zhao Y; Pi G; Zhang T
BMC Cancer; 2020 Mar; 20(1):188. PubMed ID: 32138704
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
Tang L; Ishikawa Y; Matsushita H; Jingu K
Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
[TBL] [Abstract][Full Text] [Related]
38. A novel lymph node staging system for gastric cancer including modified Union for cancer Control/American Joint Committee on cancer and Japanese Gastric Cancer Association criteria.
Gong Y; Pan S; Wang X; Zhu G; Xu H; Zhu Z
Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e27-e32. PubMed ID: 32631708
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
Abdel-Rahman O
Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
[TBL] [Abstract][Full Text] [Related]
40. A better prognostic stratification for the 8th edition of the AJCC staging system of gastric cancer by incorporating pT4aN0M0 into stage IIIA.
Chen Y; Zhang G; Zhao B; Huang C; Ling Y; Li Y; Zhou Z
Surg Oncol; 2019 Jun; 29():90-96. PubMed ID: 31196500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
